This article was originally published in RAJ Devices
Status of import restrictions on US ruminants and products
You may also be interested in...
A revised procedure is in place to temporarily list unlicensed products for use in public health emergencies.
Pfizer has announced that it does not plan to market its Amsparity adalimumab biosimilar in Europe despite it having been endorsed by the EMA in December and being in line for an imminent approval from the European Commission.
Developers of arthroscopy tubing should take additional steps to reduce the risk of patient cross-contamination, the US FDA recommends in a new draft guidance document.